Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the selection of appropriate initial drug therapy for a patient who has been determined to have a seizure disorder. He recommends taking into account co-morbidities and tailoring the therapy to the individual patient.

Disclosure:
Owns stock, stock options, or bonds from: GlaxoSmithKline

For more information on Dr. Wilner, Please visit:
www.DrWilner.org